Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Personalized electrical stimulation for cognitive impairment in demyelination patients

Official title: This Study is Designed to Evaluate the Efficacy of Personalized Alternating Current Stimulation in the Treatment of Working Memory in Patients With Inflammatory Demyelination of the Central Nervous System

Run by Xuanwu Hospital, Beijing · NCT06968039 · Data updated 2026-11-12

This study is testing if personalized electrical stimulation can help improve thinking skills in people with conditions like Multiple Sclerosis and Neuromyelitis Optica.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment85 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 31, 2024
Main results expectedJuly 1, 2027
Study endsOctober 1, 2027
Registry record updatedMay 13, 2025
Trial IDNCT06968039 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 18 to 65 with diagnosed Multiple Sclerosis or similar conditions, experiencing cognitive decline.

Probably not a fit

Patients who have had a relapse or medication changes in the past month, or those with certain medical devices, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of individualized transcranial electrical stimulation (tES) in improving cognitive function in patients with inflammatory demyelinating disorders such as Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Participants will undergo a one-time tES intervention, with cognitive performance assessed through standardized neuropsychological tests before and after the treatment. The study aims to measure improvements in cognitive domains including working memory, attention, executive function, and processing speed. The hypothesis is that personalized tES will lead to significant cognitive enhancements, providing a non-invasive therapeutic option for cognitive decline in these patients.

Why it matters

Potential benefit: If successful, this approach could offer a new non-invasive treatment option to improve cognitive function in patients with demyelinating diseases.

How similar studies have gone: While there is ongoing research in neuromodulation techniques, the specific application of personalized tES for cognitive impairment in this patient population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD), Multiple Sclerosis (MS), and other Central Nervous System Inflammatory Demyelinating Diseases that meet diagnostic criteria;
* Patients with SDMT scores \<55 or subjective cognitive decline;
* Age between 18 and 65 years, gender unrestricted;
* No relapse or medication changes in the past month;
* EDSS (Expanded Disability Status Scale) score ≤6;
* Right-handed, native Chinese speakers with sufficient educational background to understand the test instructions; -Willing to participate and have signed informed consent.-

Exclusion Criteria:

* Relapse record within the past month;
* Medication adjustment within the past month or having undergone modified electroconvulsive therapy, transcranial magnetic stimulation, or other neuromodulation techniques;
* Participating in any other clinical research within 1 month prior to enrollment or currently;
* Presence of cochlear hearing aids, cardiac pacemakers, or implanted brain stimulation devices;
* Skin integrity damage at electrode placement sites, or allergy to electrode gel or adhesives;
* History of epilepsy, hydrocephalus, central nervous system tumors, brain injury, or intracranial infections;
* Pregnant or lactating women, or those planning pregnancy in the near future;
* Scoring ≥3 on item 3 (suicide item) of the HDRS-17 or concurrent severe mental illness;
* Concurrent severe or unstable organic diseases;
* Unable to cooperate with treatment, follow-up, or clinical, EEG, and imaging data collection due to poor patient compliance;
* Other situations deemed inappropriate for study participation by the researchers.

Where it's running

  • Xuanwu Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.